Reset filter
Trefwoorden
Neoplasia ×
Meer tonen Trefwoorden
Inhoudsopgave
  1. 1. Klinische studie
  2. 2. Routinedocumentatie
  3. 3. Register-/kohortstudies
  4. 4. Kwaliteitswaarborging
  5. 5. Datastandaard
  6. 6. Patiëntenvragenlijst
  7. 7. Medisch vakgebied
    1. 7.1. Anesthesie
    1. 7.2. Dermatologie
    1. 7.3. HNO
    1. 7.4. Geriatrie
    1. 7.5. Gynaecologie/Ostetrie
    1. 7.6. Interne geneeskunde
      1. Hematologie
      1. Epidemiologie
      1. Cardiologie/Angiologie
      1. Pneumologie
      1. Gastro-enterologie
      1. Nefrologie
      1. Endocrinologie/Metabolisme
      1. Rheumatologie
    1. 7.7. Neurologie
    1. 7.8. Oogheelkunde
    1. 7.9. Palliatieve zorg
    1. 7.10. Pathologie/Forensische Geneeskunde
    1. 7.11. Kindergeneeskunde
    1. 7.12. Psychiatrie/Psychosomatisch
    1. 7.13. Radiologie
    1. 7.14. Chirurgie
      1. Algemene/maag-darm-chirurgie
      1. Neurochirurgie
      1. Plastische chirurgie
      1. Cardiothoracale chirurgie
      1. Traumachirurgie/Orthopedie
      1. Vaatchirurgie
    1. 7.15. Urologie
    1. 7.16. Tandheelkunde/MKG
Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

30 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility DRKS00003516 NCT01374789 Urinary Bladder Cancer - Eligibility

- 20-09-21 - 1 Formulier, 2 Itemgroepen, 39 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01374789

Bladder Cancer NCT01224665 - Pre-Randomization Off-Study Form Bladder Cancer #52060 S1011 NCT01224665

- 24-03-15 - 1 Formulier, 5 Itemgroepen, 24 Data-elementen, 1 Taal
Itemgroepen: Header Module, Treatment Information, Off Treatment Reason, Additional Treatment, Vital Status
S1011 Pre-Randomization Off-Study Form (#52060) Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer NCT01224665 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9399F2B7-7E68-06C0-E040-BB89AD436952

Eligibility DRKS00004052 NCT00661609 Bladder Cancer - Eligibility Advanced Bladder Cancer NCT00661609

- 17-09-21 - 1 Formulier, 2 Itemgroepen, 8 Data-elementen, 1 Taal
Itemgroepen: Inclusion criteria, Exclusion criteria
Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) See http://clinicaltrials.gov/ct2/show/record/NCT00661609

Eligibility DRKS00010322 NCT00246974 Bladder Cancer - Eligibility

- 11-12-13 - 1 Formulier, 2 Itemgroepen, 7 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00246974

Follow-Up Form Bladder Cancer (NCT00942331)

- 08-01-15 - 1 Formulier, 8 Itemgroepen, 44 Data-elementen, 1 Taal
Itemgroepen: Header, Vital Status, Treatment Status, Disease Assessment, Measurable Disease Response, Notice of New Primary, Long-Term Toxicity, Non-Protocol Therapy
CALGB 90601: Follow-Up Form Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer NCT00942331 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6591C082-D8C1-EC1C-E040-BB89AD43479B

On-Study Form Bladder Cancer NCT00014534 CALGB-90104

- 21-08-15 - 1 Formulier, 3 Itemgroepen, 61 Data-elementen, 1 Taal
Itemgroepen: Muscle Invasive Bladder Disease: Prior Treatment Affecting the Bladder, Prior Therapy Date, CCRR MODULE
On-Study Form Bladder Cancer NCT00014534 CALGB-90104 NCT00014534 NCI Cooperative Group On-Study Form-Revised (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B6E9C-942E-7181-E034-0003BA12F5E7

Hematology Laboratory Test Form Bladder Cancer (NCT00014534)

- 22-01-15 - 1 Formulier, 2 Itemgroepen, 29 Data-elementen, 1 Taal
Itemgroepen: Administrative documentation, Hematology finding
NCI Cooperative Group Hematology Laboratory Test Form (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer NCT00014534 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C02B5C-8C97-26B5-E034-0003BA12F5E7

Bladder Cancer NCT00014534 Treatment - CALGB: 90104 Eligibility Checklist - 2169226v3.0 - CALGB: 90104 Eligibility Checklist

- 09-01-15 - 1 Formulier, 1 Itemgroep, 36 Data-elementen, 1 Taal
Itemgroep: CCRR MODULE
CALGB: 90104 Eligibility Checklist Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE19FD2A-E369-6ABF-E034-0003BA12F5E7

Bladder Cancer NCT00445601 On-Study - S0337 Cystoscopy and Urine Markers Form - 2389143v1.0 - S0337 Cystoscopy and Urine Markers Form

- 20-09-21 - 1 Formulier, 4 Itemgroepen, 25 Data-elementen, 1 Taal
Itemgroepen: Header, Urine Markers, Cytoscopy, Comments
S0337 Cystoscopy and Urine Markers Form Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FE26193B-C3C0-4C67-E034-0003BA3F9857

Bladder Cancer NCT01224665 Toxicity - S1011 Adverse Event Form (#10184) - 3244012v1.0 - S1011 Adverse Event Form (#10184)

- 09-01-15 - 1 Formulier, 3 Itemgroepen, 20 Data-elementen, 1 Taal
Itemgroepen: Header Module, Adverse Events, Comments
S1011 Adverse Event Form (#10184) Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A5B1CE1B-FD09-92A4-E040-BB89AD432AC8

Bladder Cancer NCT00014534 Toxicity - CALGB: 90104 Adverse Event Form 2 - 2169496v3.0 - CALGB: 90104 Adverse Event Form 2

- 09-01-15 - 1 Formulier, 1 Itemgroep, 19 Data-elementen, 1 Taal
Itemgroep: CCRR MODULE
CALGB: 90104 Adverse Event Form 2 Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B5A58-F45B-70FF-E034-0003BA12F5E7

Bladder Cancer NCT01224665 Registration - S1011 Registration Worksheet Step 1 (#23645) - 3152651v1.0 - S1011 Registration Worksheet Step 1 (#23645)

- 09-01-15 - 1 Formulier, 7 Itemgroepen, 19 Data-elementen, 1 Taal
Itemgroepen: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, For SWOG Institutions:, Patient Information, Indicate how the patient answered the following questions on the consent form, Patient Eligibility
S1011 Registration Worksheet Step 1 (#23645) Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9386ADF9-F927-860A-E040-BB89AD4354A2

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial